1)   Bromocriptine improves glucose tolerance in obese mice via central dopamine D2 receptor-independent mechanism.
Tsuneki H, Maeda T, Takatsuki M, Sekine T, Masui S, Onishi K, Takeda R, Sugiyama M, Sakurai T, Yanagisawa M, Wada T, Sasaoka T.
PLos One. 20:e0320157

2)   Olfactory bulbectomy-induced impairment of lipid utilization leads to abnormal glucose metabolism in mice.
Sugiyama M, Tsuneki H, Onishi K, Yubune K, Yamagishi T, Sano S, Tanaka Y, Takasaki I, Sakurai T, Yanagisawa M, Koizumi K, Kadowaki M, Saito S, Wada T, Sasaoka T.
PLos One. 20:e0333176

3)   Sleep-promoting effects of preproorexin C-terminal peptide in mice.
Honda K, Tsuneki H, Ito H, Mori K, Yoshida M, Wada T, Sasaoka T.
Biochem Biophys Res Commun. 787:152760.

4)   Defective IgG Class Switching in the Spleen of TRAF5-Deficient Mice Reveals a Role for TRAF5 in CD40-Mediated B Cell Responses During Obesity-Associated Inflammation.
Wakaizumi T, Hikosaka-Kuniishi M, Ozasa Y, Sato A, Iwata C, Wada T, Sasaoka T, Morita M, So T.
Int J Mol Sci. 26:9494.